Last reviewed · How we verify
NCT07371078: TMD - TMJ - DD
Conventional, Additive and Subtractive Occlusal Splints for TMDs
NA trial testing Conventional Stabilizing Splint in TMD in 27 participants. Completed in 1 December 2025.
1 September 2025
Quick facts
| Lead sponsor | Mansoura University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 27 |
| Start date | 1 February 2025 |
| Primary completion | 1 September 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Conventional Stabilizing Splint
- Milled Stabilizing Splint
- 3D Printed Stabilizing Splint
Conditions studied
- TMD — all drugs for TMD →
- Disc Displacement — all drugs for Disc Displacement →
Sponsor
Mansoura University
Who can join
Adults 18 to 45, any sex, with TMD or Disc Displacement. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is aiming to clinically compare between occlusal splints produced by conventional, subtractive and additive techniques in regard to patient satisfaction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07371078
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for TMD
Currently open trials in the same condition.
- NCT07304557 — Effects Exercises in Temporomandibular Joint Disorders on Pain, Joint and Tongue Functions · NA · recruiting
- NCT06948162 — Exploration of the Utility of Dental-dedicated MRI for Dentistry · recruiting
- NCT07351812 — Two Treatment Modalities for Myogenous Temporomandibular Disorders · NA · recruiting
Other Mansoura University trials
Trials by the same sponsor.
- NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
- NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
- NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
- NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07371078 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University
- Last refreshed: 27 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07371078.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing